Delivery Order SPE2DB22D9244-SPE2DB25FZQ96
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $25,868.10 firm fixed-price contract is for the delivery of Xtandi 40 mg capsules to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Xtandi 40 mg capsules to the U.S. Defense Logistics Agency's (DLA) Medical Supply Chain division. The firm fixed-price delivery order, valued at $8,622.72, has an ultimate completion date of July 9, 2024. This contract is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
This award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including common and specialized medications, to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. This particular...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $8,622.72, is for the delivery of 120 capsules of the drug Xtandi 40 mg to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a significant indefinite delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the delivery of Xtandi 80 mg tablets in 60-count packages, with a ceiling value of $4,169.59 and a completion date of December 17, 2024. DMS Pharmaceutical Group is a key supplier in the federal...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The $12,934.05 delivery order is for the supply of 120 capsules of Xtandi 40 mg, a specialty medication. The IDC has a ceiling value of $499,999,999 and is valid through November 2026, enabling the DLA to issue delivery orders for a wide range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $25,868.10. It was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a single-award indefinite delivery contract (IDC) with a ceiling of up to $499,999,999 that runs through December 31, 2025. The delivery order is for the supply of the pharmaceutical product XTANDI 40 MG CAPSULE 120S. DMS Pharmaceutical Group is a key supplier in the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,678.36 firm fixed-price contract is for the delivery of Xtandi 80 mg tablets to support the recurring pharmaceutical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract, valued at $8,622.72, is for the provision of Xtandi 40 mg capsules. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive...